A detailed history of Concurrent Investment Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 9,724 shares of BSX stock, worth $889,746. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,724
Previous 9,194 5.76%
Holding current value
$889,746
Previous $708 Million 15.09%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$72.96 - $84.0 $38,668 - $44,520
530 Added 5.76%
9,724 $815 Million
Q2 2024

Jul 30, 2024

BUY
$67.33 - $77.71 $60,125 - $69,395
893 Added 10.76%
9,194 $708 Million
Q1 2024

May 07, 2024

BUY
$57.6 - $68.62 $61,401 - $73,148
1,066 Added 14.73%
8,301 $569 Million
Q4 2023

Apr 15, 2024

BUY
$48.64 - $57.81 $351,910 - $418,255
7,235 New
7,235 $418 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.